SunWay Biotech Co., LTD. (TPEX:1271)
Taiwan · Delayed Price · Currency is TWD 59.50
+0.90 (1.54%)
Sep 8, 2026, 12:26 PM CST
SunWay Biotech Co., LTD. Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 726.41 | 301.02 | 293.71 | 362.19 | 123.57 | 346.44 |
Cash & Short-Term Investments | 726.41 | 301.02 | 293.71 | 362.19 | 123.57 | 346.44 |
Cash Growth | 6.69% | 2.49% | -18.91% | 193.11% | -64.33% | 17.30% |
Accounts Receivable | 654.7 | 278.38 | 298.3 | 266.47 | 170.66 | 102.45 |
Receivables | 654.7 | 278.38 | 298.3 | 266.47 | 206.91 | 102.45 |
Inventory | 748.72 | 190.16 | 210.03 | 170.23 | 94 | 76.91 |
Prepaid Expenses | 61.38 | 9.61 | 15.46 | 9.13 | 12.26 | 2.84 |
Other Current Assets | 52.09 | 8.51 | 7.99 | 4.74 | 3.83 | - |
Total Current Assets | 2,243 | 787.67 | 825.48 | 812.76 | 440.56 | 528.63 |
Property, Plant & Equipment | 428.96 | 340.88 | 337.12 | 319.45 | 5.43 | 48.64 |
Long-Term Investments | 648.05 | 679.69 | 12.97 | 7.76 | - | 5.34 |
Goodwill | - | 2,027 | 2,027 | 2,027 | - | - |
Other Intangible Assets | 3,326 | 350.22 | 392.16 | 429.39 | 16.85 | 11.68 |
Long-Term Deferred Tax Assets | 13.11 | 10.37 | 4.22 | 6.97 | 5.92 | - |
Other Long-Term Assets | 229.55 | 266.27 | 193.76 | 136.53 | 9.47 | 13.41 |
Total Assets | 6,889 | 4,462 | 3,792 | 3,740 | 478.23 | 607.7 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 247.96 | 28.13 | 51.54 | 35.72 | 57.96 | 18.59 |
Accrued Expenses | - | - | - | - | - | 29.87 |
Short-Term Debt | 707 | 200 | - | 7.51 | 65.56 | - |
Current Portion of Long-Term Debt | - | 48.72 | - | - | - | - |
Current Portion of Leases | 18.49 | 12.2 | 17.04 | 31.55 | 2.4 | 2.51 |
Current Income Taxes Payable | 58.59 | 24.38 | 24.63 | 18.43 | 7.39 | 0.49 |
Current Unearned Revenue | 19.58 | 21.77 | 13.65 | 15.89 | 14.95 | 0.84 |
Other Current Liabilities | 451.26 | 149.68 | 116.57 | 94.3 | 38.84 | 8.34 |
Total Current Liabilities | 1,503 | 484.88 | 223.44 | 203.4 | 187.1 | 60.65 |
Long-Term Debt | 583.6 | 408.86 | - | - | - | - |
Long-Term Leases | 219.88 | 214.95 | 226.95 | 248.3 | 3.05 | - |
Long-Term Unearned Revenue | 20.28 | 23.18 | - | - | - | - |
Long-Term Deferred Tax Liabilities | 63.8 | 66.13 | 75.08 | 82.24 | - | - |
Other Long-Term Liabilities | 325.13 | - | 1.66 | 3.28 | - | - |
Total Liabilities | 2,716 | 1,198 | 527.13 | 537.21 | 190.14 | 60.65 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 770.89 | 603.89 | 603.89 | 593.89 | 209.19 | 331.35 |
Additional Paid-In Capital | 3,281 | 2,526 | 2,524 | 2,555 | - | 29.08 |
Retained Earnings | 171.1 | 152.24 | 131.06 | 51.09 | 32.82 | 195.83 |
Treasury Stock | -20.99 | -20.99 | - | - | - | - |
Comprehensive Income & Other | -30.62 | -0.34 | 3.36 | -0.68 | 46.08 | -12.6 |
Total Common Equity | 4,171 | 3,261 | 3,263 | 3,199 | 288.09 | 543.66 |
Minority Interest | 2.59 | 2.59 | 2.6 | 2.89 | - | 3.39 |
Shareholders' Equity | 4,174 | 3,264 | 3,265 | 3,202 | 288.09 | 547.05 |
Total Liabilities & Equity | 6,889 | 4,462 | 3,792 | 3,740 | 478.23 | 607.7 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,529 | 884.73 | 243.99 | 287.35 | 71.01 | 2.51 |
Net Cash (Debt) | -802.55 | -583.7 | 49.71 | 74.84 | 52.57 | 343.93 |
Net Cash Growth | - | - | -33.57% | 42.37% | -84.72% | 17.42% |
Net Cash Per Share | -12.93 | -9.68 | 0.82 | 2.44 | 2.60 | 10.01 |
Filing Date Shares Outstanding | 63.94 | 60.39 | 60.39 | 60.39 | 34.11 | 33.69 |
Total Common Shares Outstanding | 63.94 | 60.39 | 60.39 | 60.39 | 34.11 | 33.69 |
Working Capital | 740.41 | 302.79 | 602.04 | 609.36 | 253.47 | 467.99 |
Book Value Per Share | 65.24 | 54.00 | 54.03 | 52.98 | 8.44 | 16.14 |
Tangible Book Value | 844.81 | 884.3 | 843.81 | 743.36 | 271.24 | 531.98 |
Tangible Book Value Per Share | 13.21 | 14.64 | 13.97 | 12.31 | 7.95 | 15.79 |
Machinery | - | 140.06 | 100.91 | 102.56 | 1.78 | 129.24 |
Construction In Progress | - | 36.39 | 57.04 | 31.9 | - | - |
Leasehold Improvements | - | 49.24 | 58.95 | 25.58 | - | 23.19 |